Triazine Derivative as Putative Candidate for the Reduction of Hormone-Positive Breast Tumor: In Silico, Pharmacological, and Toxicological Approach

Background and objectives: Breast cancer is a heterogeneous disease that poses the highest incidence of morbidity among women and presents many treatment challenges. In search of novel breast cancer therapies, several triazine derivatives have been developed for their potential chemotherapeutic acti...

Descripción completa

Detalles Bibliográficos
Autores principales: Tayyab Imtiaz, Muhammad, Anwar, Fareeha, Saleem, Uzma, Ahmad, Bashir, Hira, Sundas, Mehmood, Yumna, Bashir, Manal, Najam, Saima, Ismail, Tariq
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193840/
https://www.ncbi.nlm.nih.gov/pubmed/34122114
http://dx.doi.org/10.3389/fphar.2021.686614

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193840/
https://www.ncbi.nlm.nih.gov/pubmed/34122114
http://dx.doi.org/10.3389/fphar.2021.686614

Ejemplares similares